{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:06:31Z","timestamp":1784905591164,"version":"3.55.0"},"reference-count":38,"publisher":"Termedia Sp. z.o.o.","issue":"3","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Complex perianal fistula, which is characterized by high occurrence and is difficult to treat with current surgical techniques, negatively affects the life quality of patients. Mesenchymal stem cells (MSCs) have emerged as a new innovative therapy in recent years due to their potent anti-inflammatory and immunomodulatory properties. Considering the high recurrence rate of complex perianal fistula, we performed this systematic review and meta-analysis to assess the long-term effects of MSCs on complex perianal fistula.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Trials with MSC treatment for complex perianal fistula were included. Analyses were conducted using Stata software. The Egger test for linear regression and Begg\u2019s funnel plot were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MSC treatment considerably improved the clinical response of complex perianal fistula at a follow-up of 24 weeks (OR = 1.86, 95% CI: 1.39-2.50), 48 weeks (OR = 2.23, 95% CI: 1.52-3.26), and 96 weeks (OR = 2.08, 95% CI: 1.17-3.68).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MSC therapy has a long-term effect on the clinical response of complex perianal fistula and should be widely promoted not only in adults but also in infants and adolescents; however, more research on this topic is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5114\/ceji.2024.144866","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:13:36Z","timestamp":1732857216000},"page":"273-281","source":"Crossref","is-referenced-by-count":3,"title":["Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis"],"prefix":"10.5114","volume":"49","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"ref-1534829","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00384-007-0334-7","article-title":"An assessment of the incidence of fistula-in-ano in four countries of the European Union","volume":"22","author":"Zanotti C","year":"2007","unstructured":"Zanotti C, Martinez-Puente C, Pascual I, et al. (2007): An assessment of the incidence of fistula-in-ano in four countries of the European Union. Int J Colorectal Dis 22: 1459-1462.","journal-title":"Int J Colorectal Dis"},{"key":"ref-1534830","first-page":"219","article-title":"Fistula-in-ano in a defined population","volume":"73","author":"Sainio P","year":"1984","unstructured":"Sainio P (1984): Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Ann Chir Gynaecol 73: 219-224.","journal-title":"Incidence and epidemiological aspects. Ann Chir Gynaecol"},{"key":"ref-1534831","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/DCR.0b013e3182099d9e","article-title":"Quality of life in perianal Crohn\u2019s disease: what do patients consider important?","volume":"54","author":"Mahadev S","year":"2011","unstructured":"Mahadev S, Young JM, Selby W, Solomon MJ (2011): Quality of life in perianal Crohn\u2019s disease: what do patients consider important? Dis Colon Rectum 54: 579-585.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534832","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-014-2104-7","article-title":"Complex anal fistula remains a challenge for colorectal surgeon","volume":"30","author":"Cadeddu F","year":"2015","unstructured":"Cadeddu F, Salis F, Lisi G, et al. (2015): Complex anal fistula remains a challenge for colorectal surgeon. Int J Colorectal Dis 30: 595-603.","journal-title":"Int J Colorectal Dis"},{"key":"ref-1534833","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.dld.2016.12.008","article-title":"French national consensus clinical guidelines for the management of Crohn\u2019s disease","volume":"49","author":"Peyrin-Biroulet L","year":"2017","unstructured":"Peyrin-Biroulet L, Bouhnik Y, Roblin X, et al. (2017): French national consensus clinical guidelines for the management of Crohn\u2019s disease. Dig Liver Dis 49: 368-377.","journal-title":"Dig Liver Dis"},{"key":"ref-1534834","doi-asserted-by":"crossref","first-page":"100808","DOI":"10.1016\/j.cpsurg.2020.100808","article-title":"Fistulizing Crohn\u2019s disease","volume":"57","author":"Lightner AL","year":"2020","unstructured":"Lightner AL, Ashburn JH, Brar MS, et al. (2020): Fistulizing Crohn\u2019s disease. Curr Probl Surg 57: 100808.","journal-title":"Curr Probl Surg"},{"key":"ref-1534835","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3748\/wjg.v24.i42.4821","article-title":"Burden and outcomes for complex perianal fistulas in Crohn\u2019s disease: Systematic review","volume":"24","author":"Pan\u00e9s J","year":"2018","unstructured":"Pan\u00e9s J, Reinisch W, Rupniewska E, et al. (2018): Burden and outcomes for complex perianal fistulas in Crohn\u2019s disease: Systematic review. World J Gastroenterol 24: 4821-4834.","journal-title":"World J Gastroenterol"},{"key":"ref-1534836","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00054725-200403000-00005","article-title":"Perianal fistulae following infliximab treatment: clinical and endosonographic outcome","volume":"10","author":"Ardizzone S","year":"2004","unstructured":"Ardizzone S, Maconi G, Colombo E, et al. (2004): Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 10: 91-96.","journal-title":"Inflamm Bowel Dis"},{"key":"ref-1534837","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.copbio.2012.05.005","article-title":"Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases","volume":"23","author":"DelaRosa O","year":"2012","unstructured":"DelaRosa O, Dalemans W, Lombardo E (2012): Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol 23: 978-983.","journal-title":"Curr Opin Biotechnol"},{"key":"ref-1534838","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.gastro.2015.08.038","article-title":"Cumulative evidence that mesenchymal stem cells promote healing of perianal fistulas of patients with Crohn\u2019s disease\u2013going from bench to bedside","volume":"149","author":"Garcia-Olmo D","year":"2015","unstructured":"Garcia-Olmo D, Schwartz DA (2015): Cumulative evidence that mesenchymal stem cells promote healing of perianal fistulas of patients with Crohn\u2019s disease\u2013going from bench to bedside. Gastroenterology 149: 853-857.","journal-title":"Gastroenterology"},{"key":"ref-1534839","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.exphem.2008.03.006","article-title":"Immunosuppression by mesenchymal stromal cells: from culture to clinic","volume":"36","author":"Jones BJ","year":"2008","unstructured":"Jones BJ, McTaggart SJ (2008): Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 36: 733-741.","journal-title":"Exp Hematol"},{"key":"ref-1534840","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garc\u00eda-Olmo D","year":"2005","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D, et al. (2005): A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48: 1416-1423.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534841","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","article-title":"Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation","volume":"55","author":"Herreros MD","year":"2012","unstructured":"Herreros MD, Garcia-Arranz M, Guadalajara H, et al. (2012): Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Dis Colon Rectum 55: 762-772.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534842","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo D","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I, et al. (2009): Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52: 79-86.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534843","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease","volume":"149","author":"Molendijk I","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H, et al. (2015): Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 149: 918-927.e6.","journal-title":"Gastroenterology"},{"key":"ref-1534844","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s J","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, et al. (2016): Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388: 1281-1290.","journal-title":"Lancet"},{"key":"ref-1534845","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-020-01636-4","article-title":"Autologous adipose-derived stem cells for the treatment of Crohn\u2019s fistula-in-ano: an open-label, controlled trial","volume":"11","author":"Zhou C","year":"2020","unstructured":"Zhou C, Li M, Zhang Y, et al. (2020): Autologous adipose-derived stem cells for the treatment of Crohn\u2019s fistula-in-ano: an open-label, controlled trial. Stem Cell Res Ther 11: 124.","journal-title":"Stem Cell Res Ther"},{"key":"ref-1534846","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/DCR.0000000000001924","article-title":"Efficacy and Safety of treatment of complex idiopathic fistula-in-ano using autologous centrifuged adipose tissue containing progenitor cells: A randomized controlled trial","volume":"64","author":"Ascanelli S","year":"2021","unstructured":"Ascanelli S, Zamboni P, Campioni D, et al. (2021) Efficacy and Safety of treatment of complex idiopathic fistula-in-ano using autologous centrifuged adipose tissue containing progenitor cells: A randomized controlled trial. Dis Colon Rectum 64: 1276-1285.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534847","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the Long-term safety and efficacy of darvadstrocel (Mesenchymal Stem Cell Treatment) in patients with perianal fistulizing Crohn\u2019s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial","volume":"65","author":"Garcia-Olmo D","year":"2022","unstructured":"Garcia-Olmo D, Gilaberte I, Binek M, et al. (2022): Follow-up study to evaluate the Long-term safety and efficacy of darvadstrocel (Mesenchymal Stem Cell Treatment) in patients with perianal fistulizing Crohn\u2019s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial. Dis Colon Rectum 65: 713-720.","journal-title":"Dis Colon Rectum"},{"key":"ref-1534848","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/ibd\/izab361","article-title":"Inspect: A retrospective study to evaluate long-term effectiveness and safety of Darvadstrocel in patients with perianal fistulizing Crohn\u2019s disease treated in the ADMIRE-CD trial","volume":"28","author":"Pan\u00e9s J","year":"2022","unstructured":"Pan\u00e9s J, Bouma G, Ferrante M, et al. (2022): Inspect: A retrospective study to evaluate long-term effectiveness and safety of Darvadstrocel in patients with perianal fistulizing Crohn\u2019s disease treated in the ADMIRE-CD trial. Inflamm Bowel Dis 28: 1737-1745.","journal-title":"Inflamm Bowel Dis"},{"key":"ref-1534849","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease","volume":"154","author":"Pan\u00e9s J","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, et al. (2018): Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 154: 1334-42.e1334.","journal-title":"Gastroenterology"},{"key":"ref-1534850","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","article-title":"Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas","volume":"27","author":"Guadalajara H","year":"2012","unstructured":"Guadalajara H, Herreros D, De-La-Quintana P, et al. (2012): Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27: 595-600.","journal-title":"Int J Colorectal Dis"},{"key":"ref-1534851","doi-asserted-by":"crossref","first-page":"8816737","DOI":"10.1155\/2020\/8816737","article-title":"Efficacy and safety of mesenchymal stem cells in treatment of complex perianal fistulas: A meta-analysis","volume":"2020","author":"Cheng F","year":"2020","unstructured":"Cheng F, Huang Z, Li Z (2020): Efficacy and safety of mesenchymal stem cells in treatment of complex perianal fistulas: A meta-analysis. Stem Cells Int 2020: 8816737.","journal-title":"Stem Cells Int"},{"key":"ref-1534852","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10151-019-01994-z","article-title":"The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis","volume":"23","author":"Choi S","year":"2019","unstructured":"Choi S, Jeon BG, Chae G, Lee SJ (2019): The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol 23: 411-427.","journal-title":"Tech Coloproctol"},{"key":"ref-1534853","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13287-020-02095-7","article-title":"Efficacy of stem cells therapy for Crohn\u2019s fistula: a meta-analysis and systematic review","volume":"12","author":"Cao Y","year":"2021","unstructured":"Cao Y, Su Q, Zhang B, et al. (2021): Efficacy of stem cells therapy for Crohn\u2019s fistula: a meta-analysis and systematic review. Stem Cell Res Ther 12: 32.","journal-title":"Stem Cell Res Ther"},{"key":"ref-1534854","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/15533506231157167","article-title":"Mesenchymal stem cells versus placebo for perianal fistulizing Crohn\u2019s disease: A systemic review and meta-analysis","volume":"30","author":"Li A","year":"2023","unstructured":"Li A, Liu S, Li L, Yu M (2023): Mesenchymal stem cells versus placebo for perianal fistulizing Crohn\u2019s disease: A systemic review and meta-analysis. Surg Innov 30: 398-405.","journal-title":"Surg Innov"},{"key":"ref-1534855","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/MPG.0000000000001562","article-title":"Surgical management of Crohn disease in children: Guidelines from the paediatric IBD Porto Group of ESPGHAN","volume":"64","author":"Amil-Dias J","year":"2017","unstructured":"Amil-Dias J, Kolacek S, Turner D, et al. (2017): Surgical management of Crohn disease in children: Guidelines from the paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr 64: 818-835.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref-1534856","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/MIB.0000000000001171","article-title":"The characteristics and long-term outcomes of pediatric Crohn\u2019s disease patients with perianal disease","volume":"23","author":"Herman Y","year":"2017","unstructured":"Herman Y, Rinawi F, Rothschild B, et al. (2017): The characteristics and long-term outcomes of pediatric Crohn\u2019s disease patients with perianal disease. Inflamm Bowel Dis 23: 1659-1665.","journal-title":"Inflamm Bowel Dis"},{"key":"ref-1534857","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MPG.0000000000001649","article-title":"Incidence and risk factors for perianal disease in pediatric Crohn disease patients followed in CEDATA-GPGE registry","volume":"66","author":"Br\u00fcckner A","year":"2018","unstructured":"Br\u00fcckner A, Werkstetter KJ, de Laffolie J, et al. (2018): Incidence and risk factors for perianal disease in pediatric Crohn disease patients followed in CEDATA-GPGE registry. J Pediatr Gastroenterol Nutr 66: 73-78.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref-1534858","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Special situations","volume":"4","author":"Van Assche G","year":"2010","unstructured":"Van Assche G, Dignass A, Reinisch W, et al. (2010): The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Special situations. J Crohns Colitis 4: 63-01.","journal-title":"J Crohns Colitis"},{"key":"ref-1534859","first-page":"603","article-title":"Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn\u2019s disease","volume":"35","author":"Hinterleitner TA","year":"1997","unstructured":"Hinterleitner TA, Petritsch W, Aichbichler B, et al. (1997): Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn\u2019s disease. Z Gastroenterol 35: 603-608.","journal-title":"Z Gastroenterol"},{"key":"ref-1534860","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gut.24.3.177","article-title":"Toward optimal use of corticosteroids in ulcerative colitis and Crohn\u2019s disease","volume":"24","author":"Lennard-Jones JE","year":"1983","unstructured":"Lennard-Jones JE (1983): Toward optimal use of corticosteroids in ulcerative colitis and Crohn\u2019s disease. Gut 24: 177-181.","journal-title":"Gut"},{"key":"ref-1534861","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0016-5085(03)00877-1","article-title":"Tacrolimus for the treatment of fistulas in patients with Crohn\u2019s disease: a randomized, placebo-controlled trial","volume":"125","author":"Sandborn WJ","year":"2003","unstructured":"Sandborn WJ, Present DH, Isaacs KL, et al. (2003): Tacrolimus for the treatment of fistulas in patients with Crohn\u2019s disease: a randomized, placebo-controlled trial. Gastroenterology 125: 380-388.","journal-title":"Gastroenterology"},{"key":"ref-1534862","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan JM","year":"2007","unstructured":"Ryan JM, Barry F, Murphy JM, Mahon BP (2007): Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149: 353-363.","journal-title":"Clin Exp Immunol"},{"key":"ref-1534863","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/stem.1483","article-title":"Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation","volume":"31","author":"Horton JA","year":"2013","unstructured":"Horton JA, Hudak KE, Chung EJ, et al. (2013): Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation. Stem Cells 31: 2231-2241.","journal-title":"Stem Cells"},{"key":"ref-1534864","doi-asserted-by":"crossref","first-page":"583409","DOI":"10.1155\/2014\/583409","article-title":"Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment","volume":"2014","author":"Pezato R","year":"2014","unstructured":"Pezato R, de Almeida DC, Bezerra TF, et al. (2014): Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment. Mediators Inflamm 2014: 583409.","journal-title":"Mediators Inflamm"},{"key":"ref-1534865","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English K","year":"2013","unstructured":"English K (2013): Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91: 19-26.","journal-title":"Immunol Cell Biol"},{"key":"ref-1534866","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","article-title":"Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells","volume":"126","author":"Ivanova-Todorova E","year":"2009","unstructured":"Ivanova-Todorova E, Bochev I, Mourdjeva M, et al. (2009): Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126: 37-42.","journal-title":"Immunol Lett"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-188350-129553","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-188350-129553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:30:13Z","timestamp":1767947413000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Long-term-efficacy-of-mesenchymal-stem-cell-treatment-for-complex-perianal-fistulas,188350,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"alternative-id":["188350"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2024.144866","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}